Gramocef-O Dry Syrup contains Cefixime, a third-generation cephalosporin antibiotic, at a concentration of 100mg per 5ml. It is indicated for the treatment of a variety of bacterial infections caused by susceptible strains, including respiratory tract infections, urinary tract infections, otitis media, pharyngitis, and gonorrhea. Cefixime exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The dry syrup formulation is particularly suitable for pediatric patients and those with difficulty swallowing tablets, ensuring accurate dosing and improved compliance. After reconstitution, the suspension should be stored as per guidelines and used within the recommended period to maintain efficacy. Dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, while hypersensitivity reactions, though rare, require immediate medical attention. Gramocef-O Dry Syrup should be used with caution in patients with a history of penicillin or cephalosporin allergy. It is essential to complete the full prescribed course to prevent the development of antibiotic resistance. Consultation with a healthcare professional is advised prior to use.